CKD end-stage (n = 5)

Not CKD end-stage (n = 44)

P

Age

Sex-ratio

Delay between early symptomatology and start of treatment greater than 3 months

Hypertension

Mean serum creatinine

Renal insufficiency

Anemia

Lymphopenia

C3 Hypocomplementemia

CH50 Hypocomplementemia

Anti-ENA

Anti-dsDNA

Mean proteinuria

Nephrotic syndrome

Microscopic hematuria

Leukocyturia

40.5 ± 5.2

2H/3F

1 cas (20%)

3 cas (60%)

56.7 ± 12.1

5 cas (100%)

5 cas (100%)

1 cas (20%)

0 cas (0%)

0 cas (%)

1 cas (20%)

1 cas (20%)

3 cas (60%)

3.3 ± 2.6

3 cas (60%)

2 cas (40%)

31.6 ± 8.9

9H/35F

9 cas (20.45%)

9 cas (20.45%)

19.2 ± 9.9

14 cas (31.81%)

38 cas (86.36%)

6 cas (13.63%)

1 cas (2.27%)

1 cas (2.27%)

19 cas (43.18%)

7 cas (15.90%)

24 cas (54.54%)

3.2 ± 2.6

15 cas (34.09%)

13 cas (29.54%)

0.555

0.396

0.239

0.091

0.785

0.718

0.366

0.615

0.448

0.446

0.854

0.041

0.717

0.594

0.017

0.019